Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) Announces Expected Disclosure Date for FY2024 Financial Results (Tentative Release Scheduled for 2025-02-25)

Posted on February 14, 2025July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) Announces Expected Disclosure Date for FY2024 Financial Results (Tentative Release Scheduled for 2025-02-25)

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-02-14

Disclosure Type: Pre-announcement of Disclosure of Financial Results (Informational Disclosure)

💡 3-Second Summary

Celltrion has announced that its tentative financial results for the fiscal year starting January 1, 2024, and ending December 31, 2024, are scheduled to be disclosed on February 25, 2025.

📊 1. [Key Disclosure Content & Key Metrics Summary]

  • Reporting Period: January 1, 2024, to December 31, 2024 (FY2024)
  • Expected Disclosure Date: February 25, 2025
  • Status of Figures: The financial results to be disclosed on the expected date are tentative (provisional) and subject to change based on the review results of the independent external auditor.
  • Data Availability: Following the official disclosure of the financial results, related materials (in Korean and English) will be made available in the IR section of Celltrion’s official website (https://www.celltrion.com).
  • Schedule Flexibility: The expected disclosure date is subject to change depending on company circumstances.

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Official Establishment of the Earnings Timeline: This pre-announcement is a administrative notification to provide investors with advance notice of the upcoming earnings release date. It establishes the official timeline for when Celltrion’s FY2024 tentative results will become publicly available.
  • Potential for Variations in Provisional Data: As noted in the filing, the upcoming release consists of provisional figures. Because these numbers are subject to review by the independent external auditor, adjustments may occur, and the scheduled date itself remains subject to potential shifts depending on internal circumstances.
  • Reference to Official IR Materials: Related IR documents in both Korean and English are scheduled to be uploaded to the company’s website following the official release, providing the primary source for verifying the specific reported financial metrics.

📝 Editor’s Comment (by K-STOCK Editor)

This pre-announcement is a routine administrative filing designed to inform the market of the upcoming earnings release timeline in advance. Consequently, this disclosure itself contains no specific qualitative data or financial metrics regarding Celltrion’s operational performance during the fiscal year.

The primary event for investors will be the actual publication of the tentative financial figures scheduled for February 25, 2025. Investors should bear in mind that the initial figures will be provisional and subject to potential adjustments based on the final external audit review, and the release date itself may be adjusted depending on company circumstances.

Going forward, market participants should monitor whether the tentative disclosure is filed as planned on February 25, and utilize the official IR materials subsequently published on the company’s website to evaluate the verified annual financial results.

📢 Disclaimer & Source Information

Source: This content has been newly structured and written based on official disclosure data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) Delists Preferred DRs from Luxembourg… Streamlines Global Trading to London Stock Exchange
Next Post: [Disclosure] Celltrion (068270) Secures European Commission (EC) Final Marketing Authorization for ‘Eylea Biosimilar (CT-P42)’

Related Posts

[Disclosure] Hanwha Aerospace (012450) – (Correction) Advance Notice of Financial Results Disclosure (Q2 Earnings Release Date Rescheduled to July 30) Disclosures
[Disclosure] HPSP(403870) Reaches Record-High Annual Operating Profit of KRW 95.2B (+11.8%) Despite Temporary Q4 Softness Semiconductors
[Disclosure] HANMI Semiconductor (042700) Designated as Short-Selling Overheated Stock: Short Transactions Banned for April 8 Semiconductors
[Disclosure] Hanwha Ocean (042660) Announces Expiration of Lock-up Period for 104,438,643 Common Shares, Set to be Released on June 13 Disclosures
[Disclosure] LEENO Industrial (058470) Submits Clean ‘Unqualified’ Audit Report with ₩278B Revenue and ₩124.2B Operating Profit… Solid Fundamentals of the Semiconductor Test Socket Leader Semiconductors
[Disclosure] Alteogen (196170) to Receive USD 25,000,000 (Approx. KRW 35.05B) Milestone Technical Fee from MSD for ALT-B4 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme